Fairjourney Biologics
VC Fund
Porto Alegre, Brazil
Fairjourney Biologics is a VC fund in Porto Alegre focused on Biotechnology. FairJourney Biologics, a fee-for-service company, was founded in 2012 and has been profitable since 2013. The fast growth coupled to financial independence is a market validation of the excellence in antibody discovery and engineering and a guarantee of stable and strong partnerships.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Fairjourney Biologics invests in
Stages Fairjourney Biologics invests in
Countries Fairjourney Biologics invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
António Parada
CEO & Co-founder
|
CEO & Co-founder | Total investments: 0 | Find email | |
Maria Pajuelo
Co-founder & Chief Scientific Officer
|
Co-founder & Chief Scientific Officer | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Flow Eighteen38 is to facilitate and accelerate antibody projects by delivering purified proteins. | $5.4M / Corporate Round / Mar 08, 2022 |
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Fairjourney Biologics invest in?
Fairjourney Biologics invests primarily in Biotechnology startups, most often at Corporate Round stage. Most of the 1 investments tracked by Shizune back companies in Portugal. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Fairjourney Biologics?
Public channels for Fairjourney Biologics include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Fairjourney Biologics?
The team at Fairjourney Biologics includes António Parada (CEO & Co-founder) and Maria Pajuelo (Co-founder & Chief Scientific Officer). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
